作者: Raphael Twerenbold , Karin Wildi , Cedric Jaeger , Maria Rubini Gimenez , Miriam Reiter
DOI: 10.1161/CIRCULATIONAHA.114.014245
关键词:
摘要: Background—It is unknown whether more sensitive cardiac troponin (cTn) assays maintain their clinical utility in patients with renal dysfunction. Moreover, their optimal cutoff levels in this vulnerable patient population have not previously been defined. Methods and Results—In this multicenter study, we examined the clinical utility of 7 more sensitive cTn assays (3 sensitive and 4 high-sensitivity cTn assays) in patients presenting with symptoms suggestive of acute myocardial infarction. Among 2813 unselected patients, 447 (16%) had renal …